Leukemia reconstitution in vivo is driven by cells in early cell cycle and low metabolic state
Luca Trentin,
Manon Queudeville,
Sarah Mirjam Eckhoff,
Nabiul Hasan,
Vera Münch,
Elena Boldrin,
Felix Seyfried,
Stefanie Enzenmüller,
Klaus-Michael Debatin,
Lüder Hinrich Meyer
Affiliations
Luca Trentin
Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Germany
Manon Queudeville
Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Germany
Sarah Mirjam Eckhoff
Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Germany
Nabiul Hasan
Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Germany
Vera Münch
Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Germany;International Graduate School in Molecular Medicine, Ulm University, Germany
Elena Boldrin
Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Germany;International Graduate School in Molecular Medicine, Ulm University, Germany
Felix Seyfried
Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Germany
Stefanie Enzenmüller
Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Germany
Klaus-Michael Debatin
Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Germany
Lüder Hinrich Meyer
Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Germany
In contrast to well-established hierarchical concepts of tumor stem cells, leukemia-initiating cells in B-cell precursor acute lymphoblastic leukemia have not yet been phenotypically identified. Different subpopulations, as defined by surface markers, have shown equal abilities to reconstitute leukemia upon transplantation into immunodeficient mice. Using a non-obese diabetes/severe combined immunodeficiency human acute lymphoblastic leukemia mouse model and cell cycle analysis annotating cells to distinct cycle phases, we functionally characterized leukemia-initiating cells and found that cells in all stages of the cell cycle are able to reconstitute leukemia in vivo, with early cycling cells (G1blow population) exhibiting the highest leukemia-initiating potential. Interestingly, cells of the G2/M compartment, i.e. dividing cells, were less effective in leukemia reconstitution. Moreover, G1blow cells were more resistant to spontaneous or drug-induced cell death in vitro, were enriched for stem cell signatures and were less metabolically active, as determined by lower levels of reactive oxygen species, compared to G2/M stage cells. Our data provide new information on the biological properties of leukemia-initiating cells in B-cell precursor acute lymphoblastic leukemia and underline the concept of a stochastic model of leukemogenesis.